UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
RVMDW holding history
Revolution Medicines, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVMDW overviewAll 13F holders of RVMDWFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,461
- Value
- $23.1K
- % of portfolio
- <0.1%
- Quarters held
- 7
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,461 | $23.1K | <0.1% | +1,575+177.8% | Added | Holders |
| Q1 2026 | 886 | $1.59K | <0.1% | +886 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −2,692−100.0% | Sold out | Holders |
| Q4 2024 | 2,692 | $485 | <0.1% | +2,664+9,514.3% | Added | Holders |
| Q3 2024 | 28 | $4 | <0.1% | −447−94.1% | Reduced | Holders |
| Q2 2024 | 475 | $48 | <0.1% | +384+422.0% | Added | Holders |
| Q1 2024 | 91 | $17 | <0.1% | −880−90.6% | Reduced | Holders |
| Q4 2023 | 971 | $320 | <0.1% | +971 | New | Holders |